The Synergistic Effects of Fine Particulate Matter and High Humidity on Allergic Asthma: An Association with TRPV4/MAPK Pathway Activation
Identifying environmental factors contributing to allergic asthma is critical for effective prevention. PM<sub>2.5</sub>, a major environmental pollutant, and high relative humidity frequently coexist in urban and industrialized regions, particularly when ventilation is poor. However, the combined effects of PM<sub>2.5</sub> and humidity remain unclear. This study used a murine asthma model, exposing male Balb/c mice sensitized with ovalbumin (OVA) to PM<sub>2.5</sub> (75 μg/m<sup>3</sup> and 35 μg/m<sup>3</sup>), based on China's Ambient Air Quality Standards (GB3095-2012), and/or varying relative humidity levels in a controlled chamber. Allergic asthma severity was evaluated through histopathological changes, pulmonary function, Th1/Th2 balance, mucus hypersecretion, and inflammatory factor levels, alongside the activation of TRPV4 and MAPK signaling pathways (ERK, p38MAPK, and JNK). The results showed that high humidity (90%) or PM<sub>2.5</sub> exposure alone had minimal impact, but combined exposure to 75 μg/m<sup>3</sup> PM<sub>2.5</sub> and 90% humidity markedly aggravated airway hyperresponsiveness, inflammation, and mucus hypersecretion. These changes coincided with enhanced TRPV4 activation and MAPK signaling, particularly p38MAPK and JNK, while ERK1/2 remained unaffected. A lower PM<sub>2.5</sub> concentration (35 μg/m<sup>3</sup>) combined with 90% humidity had a weaker impact. Blocking TRPV4 with HC-067047 effectively mitigated asthma exacerbation caused by combined exposure. These findings demonstrate that co-exposure to PM<sub>2.5</sub> and high humidity dose-dependently exacerbates allergic asthma, an effect likely mediated by TRPV4-MAPK pathway activation. Targeting TRPV4 may offer a potential therapeutic strategy to mitigate asthma exacerbation in environments with high humidity and PM<sub>2.5</sub>.
Authors
- baizhan li
- Yang Xu (ORCID: https://orcid.org/0000-0002-0340-1163)
- Chenqiu Du (ORCID: https://orcid.org/0000-0002-2110-180X)
- Fangxin Fang
- Ping Ma
- Ziyu Shu
- Yang Wu
- Runming Yao
- Miao Guo
- Yan Li
Institutions
- Chongqing University (CN)
- Tianjin Chengjian University (CN)
- Hubei University of Science and Technology (CN)
- Ezhou Central Hospital (CN)
- Imperial College London (GB)
- Dali University (CN)
- University of Reading (GB)
Publication Details
- Journal
- Toxics
- Published
- 2026-03-03
- DOI
- https://doi.org/10.3390/toxics14030219
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00